| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.54B | 47.68B | 44.89B | 45.13B | 40.23B | 35.21B |
| Gross Profit | 5.08B | 5.94B | 5.32B | 5.91B | 6.14B | 5.65B |
| EBITDA | 2.28B | 2.55B | 2.79B | 2.93B | 3.55B | 3.38B |
| Net Income | 1.15B | 3.78B | 1.42B | 1.63B | 2.31B | 2.00B |
Balance Sheet | ||||||
| Total Assets | 51.82B | 55.29B | 52.34B | 51.38B | 47.27B | 42.85B |
| Cash, Cash Equivalents and Short-Term Investments | 20.43B | 26.78B | 20.68B | 20.00B | 21.42B | 21.03B |
| Total Debt | 7.22B | 6.71B | 7.28B | 7.27B | 6.77B | 6.34B |
| Total Liabilities | 12.98B | 14.51B | 13.48B | 14.25B | 12.36B | 11.22B |
| Stockholders Equity | 38.83B | 40.78B | 38.85B | 37.12B | 34.90B | 31.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.33B | 1.04B | -1.68B | 685.32M | 549.54M |
| Operating Cash Flow | 0.00 | 2.66B | 2.23B | -60.60M | 2.50B | 2.03B |
| Investing Cash Flow | 0.00 | 3.26B | -1.31B | 982.48M | -2.45B | -1.88B |
| Financing Cash Flow | 0.00 | -820.64M | -233.82M | 253.50M | 183.08M | 883.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥60.10B | 8.50 | ― | 2.44% | 3.38% | 57.67% | |
70 Outperform | ¥65.54B | 19.80 | ― | 3.98% | 0.60% | -6.50% | |
64 Neutral | ¥32.10B | 9.20 | ― | 0.72% | 6.21% | 167.11% | |
63 Neutral | ¥69.85B | 22.50 | ― | 0.34% | 10.22% | 13.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥196.68B | 9.92 | 7.56% | 2.84% | 2.53% | -4.69% | |
56 Neutral | ¥89.31B | 10.54 | ― | 3.59% | 6.25% | 246.08% |